FEATURED NEWS

• HDA Statement on COVID-19 Preparedness

  March 5, 2020

  The Healthcare Distribution Alliance (HDA) released the following statement on distribution industry preparedness for the novel COVID-19 “coronavirus” outbreak.

• AAOA Celebrates Two Years of Working with Stakeholders to Help Address Prescription Opioid Safety

  February 25, 2020

  This month, Allied Against Opioid Abuse (AAOA) celebrates its second year of working with stakeholders across the healthcare industry to raise awareness among patients, pharmacists, providers and the public about prescription opioid safety.

• Conley and Cowman to Lead HDA Research Foundation Board Of Directors

  February 25, 2020

  The HDA Research Foundation announced Michael Conley, Vice President and Head, Trade Operations and Analytics, Novartis Pharmaceuticals Corporation, as Chairman of its Board of Directors. Craig Cowman, Executive Vice President, Global Sourcing, Cardinal Health, is Vice Chairman.

• Healthcare Distribution Alliance Names Chip Davis President and Chief Executive Officer

  February 10, 2020

  The Healthcare Distribution Alliance (HDA) Board of Directors’ Executive Committee today announced the appointment of Chester “Chip” Davis, Jr., JD, to the position of President and Chief Executive Officer. Mr. Davis will join HDA during March of this year. Chip joins HDA coming from the Association for Accessible Medicines (AAM), the nation’s leading trade association for manufacturers of generic and biosimilar medicines, where he has served as President and Chief Executive Officer since 2015.

• HDA Responds to GAO Report on Suspicious Orders

  February 3, 2020

  HDA Executive Vice President of Government Affairs Patrick Kelly released the following statement in response to a new Government Accountability Office (GAO) report, Drug Control: Actions Needed to Ensure Usefulness of Data on Suspicious Opioid Orders.